Literature DB >> 10331508

Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease.

S Ohga1, N Kimura, H Takada, M Nagano, K Ohshima, A Nomura, K Muraoka, H Take, S Yamamori, T Hara.   

Abstract

To assess the abnormal T-cell expansion in chronic active Epstein-Barr virus infection (CAEBV), T-cell antigen receptor (TCR) repertoire was analyzed in four patients with the disease. All fulfilled the diagnostic criteria of CAEBV, presenting with fever, hepatosplenomegaly, cytopenia, abnormal high titers of anti EBV-antibodies, and positive EBV genome of unknown cause. Southern blotting probed with EBV-terminal repeats and TCR Cbeta gene indicated clonal expansion of the infected cells in 3 and 2 patients, respectively. The number of CD4+ HLA-DR+ cells appreciably increased in patients 1 (59%) and 2 (24%), who had a coronary aneurysm and central nervous system involvement, respectively. TCR gene expression examined by the inverse polymerase chain reaction methods revealed that Vbeta gene usages were preferential in all patients (Vbeta7 and Vbeta12: patient 1, Vbeta4: patient 2, Vbeta13: patients 3 and 4), compared with those in healthy controls. Valpha18 gene expression was remarkably high in patients 1 and 2. Moreover, Jbeta gene expression was skewing in the reigning Vbeta clones in all patients. Vbeta4-Jbeta1.5 and Vbeta13-Jbeta1.5 genes were clonally expressed in patients 2 and 4, respectively. These results suggest that CAEBV is associated with the restricted diversity of T-cells, which may stem from the sustained expansion of oligoclonal T-cells possibly driven by conventional viral antigens, but not, superantigens. Although the study is limited by the small number of patients, the unbalanced T-cell repertoire might contribute to the evolution of T-lymphoproliferative disease, otherwise, imply the innate defective immunity to EBV in CAEBV patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331508     DOI: 10.1002/(sici)1096-8652(199905)61:1<26::aid-ajh6>3.0.co;2-r

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

1.  Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.

Authors:  Michiko K Oyoshi; Hiroshi Nagata; Nobuhiro Kimura; Yu Zhang; Ayako Demachi; Toshiro Hara; Hirokazu Kanegane; Yoshinobu Matsuo; Tomohiro Yamaguchi; Tomohiro Morio; Atsuyoshi Hirano; Norio Shimizu; Kohtaro Yamamoto
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease.

Authors:  S Ohga; E Kubo; A Nomura; H Takada; N Suga; E Ishii; A Suminoe; T Inamitsu; A Matsuzaki; N Kasuga; T Hara
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

3.  Successful unrelated cord blood transplantation for Epstein-Barr virus-associated lymphoproliferative disease with hemophagocytic syndrome.

Authors:  Taikai Toubo; Naohiro Suga; Shouichi Ohga; Akihiko Nomura; Yasuhiro Onoe; Hidetoshi Takada; Toshiro Hara
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

4.  Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection.

Authors:  S Toyabe; W Harada; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

5.  Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infection.

Authors:  Tomoyuki Uchiyama; Kimito Arai; Takako Yamamoto-Tabata; Kanji Hirai; Kouji Kishimoto; Yoshiko Nakamura; Takamichi Hattori
Journal:  J Neurol       Date:  2005-03-04       Impact factor: 6.682

Review 6.  Epstein-Barr virus-associated lymphomas.

Authors:  Claire Shannon-Lowe; Alan B Rickinson; Andrew I Bell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

7.  A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Authors:  Keisuke Kawamoto; Hiroaki Miyoshi; Takaharu Suzuki; Yasuji Kozai; Koji Kato; Masaharu Miyahara; Toshiaki Yujiri; Ilseung Choi; Katsumichi Fujimaki; Tsuyoshi Muta; Masaaki Kume; Sayaka Moriguchi; Shinobu Tamura; Takeharu Kato; Hiroyuki Tagawa; Junya Makiyama; Yuji Kanisawa; Yuya Sasaki; Daisuke Kurita; Kyohei Yamada; Joji Shimono; Hirohito Sone; Jun Takizawa; Masao Seto; Hiroshi Kimura; Koichi Ohshima
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941

8.  Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.

Authors:  Haijuan Xiao; Bing Hu; Rongmu Luo; Huili Hu; Junmei Zhang; Weiying Kuang; Rui Zhang; Li Li; Gang Liu
Journal:  Virol J       Date:  2020-10-29       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.